BridgeMD
Tests treatment safety and results for H. Pylori Infection
Official title Efficacy of Vonoprazan Based Dual and Triple Therapy for Patient With Helicobacter Pylori Infection
ClinicalTrials.gov ID: NCT07045688
What this study is testing
What is Efficacy of Vonoprazan based dual therapy for naive patient with Helicobacter Pylori infection?
Efficacy of Vonoprazan based dual therapy for naive patient with Helicobacter Pylori infection is an investigational medicine, being studied as a potential treatment for h. pylori infection.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study aims to assess Efficacy of vonoprazan based dual and triple therapy for naïve patient with Helicopacter Pylori infection in Sohag Government .
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 and older
You may be able to join if
- Age: \>18 years old.
- H. pylori infection: Confirmed by histopathology or non-invasive tests (e.g., stool antigen test).
You likely can't join if
- Prior H. pylori treatment: Previous treatment for H. pylori infection.
- Allergies: Known allergies to study medications or components.
- Patients cannot finish treatment course.
- Patient missed follow up.
- Patients refusing or neglecting test of cure for H. pylori.
The study team makes the final eligibility decision.
Where it's taking place
- Sohag, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Sohag, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.